Santiago Quirce
- Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI Guidelines ‐ recommendations on the use of biologicals in severe asthma
2020/02/08 by Ioana Agache, Jessica Beltrán, Jessica Beltran +43 · 406 citations
Medicine · #Asthma #Asthma and respiratory diseases #Benralizumab #Dupilumab #Eosinophil #Immunoglobulin E #Immunology #Internal medicine #Medicine #Mepolizumab #Omalizumab #Pediatrics #Pharmaceutical studies and practices #Respiratory and Cough-Related Research
- EAACI Guidelines on Environmental Science for Allergy and Asthma—Evidence‐Based Recommendations for Prevention and Public Health Action to Mitigate the Impact of Pollen Exposure on Respiratory Allergy
2026/06/26 by Lorenzo Cecchi, Isabella Annesi‐Maesano, Benedetta Biagioni +22 · 1 voice
Medicine · #Allergic Rhinitis and Sensitization #Asthma and respiratory diseases #Occupational exposure and asthma